GTB-5550 in Advanced Solid Tumors
NCT07541573
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
175
Enrollment
OTHER
Sponsor class
Conditions
Tri-specific Killer Engager
Solid Tumor
Advanced Solid Tumor
Interventions
DRUG:
GTB-5550
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
[object Object]